Pharma Technology Inc., the oral solid dose process equipment…PHARMA TECHNOLOGY reveals its growth strategy 2025
Pharma Technology, with more than 25 years of experience…The role of Quality Control in the Pharmaceutical Industry
The pharmaceutical solid dose manufacturing process is increasingly fast-moving…New agent in Romania to represent Pharma Technology
We are pleased to announce our new collaboration with…New project industrial building
Planning of the project June 2016 – November 2018…eFlex vs. iSeries
The Challenge Today we often hear about intelligent machines,…
Today we often hear about intelligent machines, integration in production lines, and efficiency. So, we decided to start a comparison between two of our tablet dedusting solutions. The goal is to compare our eFlex product line (operational efficiency) to the iSeries line (operational efficiency and many other functionalities). “The purpose of this article is to help our customers make the right choice when purchasing one of our equipment. This investment must meet today’s demands but also perhaps the challenges of tomorrow” says Martial DOLLINGER – CEO of Pharma Technology.
With this analysis, we will try to clarify the differences between these two versions, both operationally and financially, but also from an added value point of view.
To do this, we have taken two piece of equipment and measured the quality of dust removal with the exact same physical conditions of use (same tablets, same tablet press, same speed, same vacuum, etc…).
The eFlex is the best cost-efficient solution if the customer does not have containment issues and if he does not need extended interactions between different production machines.
If the machine should be integrated in a production line with possible containment upgrades, if extended and customisable interactions between different production machines are needed, if there is a desire for centralizing production information in a single reporting protocol, then the iSeries is certainly one of the most advanced machines on the market.